Target- |
MechanismImmunostimulants |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.China |
First Approval Date02 Feb 2000 |
100 Clinical Results associated with Zhongke Biopharmaceutical Co. Ltd.
0 Patents (Medical) associated with Zhongke Biopharmaceutical Co. Ltd.
100 Deals associated with Zhongke Biopharmaceutical Co. Ltd.
100 Translational Medicine associated with Zhongke Biopharmaceutical Co. Ltd.